SelCIDs (Celgene)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSelCIDs (Celgene)
Drug Alias NamePDE4/TNFalpha inhibitors (Celgene)selective cytokine inhibitory drugs (Celgene)CC-10083CC-110036CC-110052 +[21] 
ClassificationSmall molecules
Mechanisms of ActionPhosphodieterase 4 inhibitorsTNF alpha synthesis inhibitorsAngiogenesis inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsInflammationAutoimmune DiseasesHeart Failure +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelgene Corp
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesHeart Failure +[5] 

Other Information

ATC CodeN/A
Related LinksN/A